Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Operating Leases (2019 - 2025)

Historic Operating Leases for Integra Lifesciences Holdings (IART) over the last 7 years, with Q3 2025 value amounting to $174.8 million.

  • Integra Lifesciences Holdings' Operating Leases fell 442.34% to $174.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.8 million, marking a year-over-year decrease of 442.34%. This contributed to the annual value of $181.5 million for FY2024, which is 36.4% down from last year.
  • According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Operating Leases is $174.8 million, which was down 442.34% from $173.4 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Operating Leases registered a high of $186.4 million during Q1 2024, and its lowest value of $102.1 million during Q1 2022.
  • Over the past 5 years, Integra Lifesciences Holdings' median Operating Leases value was $173.4 million (recorded in 2025), while the average stood at $158.6 million.
  • In the last 5 years, Integra Lifesciences Holdings' Operating Leases plummeted by 670.91% in 2022 and then surged by 6816.05% in 2023.
  • Integra Lifesciences Holdings' Operating Leases (Quarter) stood at $105.1 million in 2021, then surged by 63.69% to $172.0 million in 2022, then grew by 5.86% to $182.1 million in 2023, then dropped by 0.36% to $181.5 million in 2024, then decreased by 3.7% to $174.8 million in 2025.
  • Its Operating Leases was $174.8 million in Q3 2025, compared to $173.4 million in Q2 2025 and $175.6 million in Q1 2025.